Menopause and facial aging: assessment in facial harmonization

A relevant share of the patients who seek facial harmonization are in the perimenopause and postmenopause age range. Many describe the same feeling: "my face changed overnight." What the professional sees is a combination of chronological aging, photoaging, loss of volume and of skin quality, and a hormonal change that adds to all of it.

This text is a review and guides the reasoning of the assessment. It does not indicate a product, volume or technique, which are decisions for the qualified professional, according to the rules of their professional council. Hormone therapy and general health belong to the physician who follows the patient.

What changes in the face during and after menopause?

The review literature describes changes in several layers, which add to those of natural aging. The picture varies a great deal from one woman to another.

The point is not "menopause ages the face," but rather "menopause can accelerate or reveal processes that were already underway." See the overall picture in facial aging by layers.

What should you ask in the medical history?

Beyond the outline in medical history in facial harmonization, it is worth investigating:

• Current phase: perimenopause, recent menopause or established postmenopause.
• Hormone therapy: whether she uses it, which type and who follows it.
• Perceived changes: thinner skin, dryness, loss of volume, hair loss.
• Recent weight loss or use of medications that alter the face (see facial volume loss after weight loss).
• Bone health: osteopenia or osteoporosis may be relevant for interpreting resorption.
• Associated diseases: hypertension, diabetes, anticoagulant use, which influence risk.
• Expectations: what the patient considers acceptable and what she wants to recover.

How is planning usually organized?

Many professionals work with the idea of layers: skin, volume, support and facial expression. The plan, at the professional's discretion, tends to follow the question "what is missing, and what matters most first?"

Skin quality

Thin, inelastic skin responds less to volume strategies alone. Dermatological care, hydration and, in some plans, biostimulators or complementary technologies enter the reasoning. The expectation should be of gradual improvement, not of "young skin."

Volume replacement

Volume loss in the midface and in folds can be addressed with hyaluronic acid, always in doses that respect the proportions of the face. See aging of the midface and aging of the chin and jaw.

Support and contour

Loss of contour in the lower third is usually the strongest concern. See lower third laxity. For very lax tissue, injectables have a ceiling, and a surgical referral should be considered.

Dynamic wrinkles

Botulinum toxin remains the target for expression lines, but remember that thin skin makes static lines more evident, and toxin alone does not solve them.

Which risks call for special attention?

Thin skin and fat loss increase the visibility of any irregularity and the risk of a Tyndall effect with superficial product. The association with other conditions, such as anticoagulant use or diabetes, changes the risk of bleeding and infection (see diabetes and injectable procedures and anticoagulants and injectable procedures). The general risks, including vascular occlusion, apply to all patients, with hyaluronidase available whenever hyaluronic acid is used.

How do you talk with the patient?

Many women arrive with a feeling of loss. The conversation should be welcoming, without feeding the fear of aging and without promising a return to the face of before.

Record the relevant information in the patient record and update the informed consent with the specific risks. For other angles, see facial harmonization in patients over 50 and hormone therapy and facial planning.

How does Harmy help in the conversation?

Harmy shows the effect of volume in the marked areas from a front photo. For the patient in menopause, this is useful for visualizing the effect of better-supported cheekbones, a softened fold or a more defined contour, without promising the real result.

The projection does not show an improvement in skin quality, so explain to the patient that it represents volume (and toxin only in the glabella and the chin). For the flow, see how to use Harmy.

Review quiz

The face in menopause is the result of several layers changing at the same time. A good plan respects that complexity, works in stages, speaks honestly about the limits and leaves hormone follow-up to those with the competence to do it.